{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"33"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"98"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"description":"The primary feasibility measures are retention and adherence. This outcome, retention, is the percentage of patient who remain in the study for 24 weeks.","groups":[{"description":"Participants receive a letter from their physician advising them to quit smoking, and undergo a 15-30-minute smoking-cessation counseling session by a trained research staff.\n\nThe participants are educated and motivated about the importance of quitting smoking, and cancer-specific quitting issues. They will be called by Quitline in 2-3 days and receive a fact sheet about benefits of SC for cancer patients.\n\nParticipants receive 8 weeks of nicotine replacement patches and up to 5 proactive telephone calls over a 12-week period.\n\nParticipants also learn behavioral tips and coping skills.","id":"OG000","title":"Arm I - Quitline"},{"description":"Participants receive a letter from their physician advising them to quit smoking, the importance of quitting smoking for cancer patients, and a copy of the National Cancer Institute's \"Clearing the Air\" smoking cessation booklet. Participants also receive standard of care from their oncology and other treatment providers which may or may not include nicotine replacement therapy.","id":"OG001","title":"Arm II - Usual Care"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All randomized participants","reportingStatus":"POSTED","timeFrame":"24 Weeks","title":"Feasibility of a Smoking Cessation Intervention Among Cancer Patients","type":"PRIMARY","unitOfMeasure":"Participants"}